export default function Igf1OverviewPanel() {
  return (
    <div className="reta-overview">

      <p className="reta-overview__opener">
        IGF-1 is the growth factor your liver naturally produces in response to growth hormone. It drives muscle growth, tissue repair, and metabolism throughout the body. Injecting it exogenously bypasses every feedback loop your body uses to regulate how much growth signaling is safe &mdash; and that bypass creates real risks, including acute blood sugar crashes and a cancer growth signal, alongside the anabolic benefit.
      </p>

      <div className="reta-overview__profile">
        <div className="reta-overview__profile-label">Profile 1</div>
        <h3 className="reta-overview__profile-heading">The Recovery-Curious Person &mdash; muscle repair, injury healing</h3>
        <blockquote className="reta-overview__profile-think">&ldquo;I keep hearing IGF-1 mentioned for muscle repair and injury recovery. If my body already makes it, what does actually injecting it extra do?&rdquo;</blockquote>
        <p className="reta-overview__profile-why-heading">Why they&rsquo;re excited</p>
        <ol className="reta-overview__profile-why">
          <li><strong>IGF-1 is genuinely central to muscle repair &mdash; it activates stem cells in muscle</strong><br />After muscle damage, satellite cells (muscle stem cells) are activated by IGF-1 to proliferate and repair the tissue. This is real biology, not just theoretical. The repair mechanism is well-established and is part of why the compound has legitimate clinical use in certain rare growth deficiencies.</li>
          <li><strong>Growth hormone raises IGF-1, and GH compounds are part of the legitimate recovery conversation</strong><br />Much of the GH peptide discussion &mdash; ipamorelin, CJC-1295 &mdash; is really a discussion about raising IGF-1 through the body&rsquo;s own production system. Understanding IGF-1&rsquo;s role explains why people use those compounds for recovery in the first place.</li>
        </ol>
        <p className="reta-overview__profile-check-heading">Reality check</p>
        <p className="reta-overview__profile-check">Injecting IGF-1 is very different from raising it through GH peptides. GH-axis peptides let your body&rsquo;s own feedback loops control how much IGF-1 you make &mdash; which includes shutting down production when it gets high enough. Injecting IGF-1 directly bypasses those controls entirely. It also lowers blood sugar (IGF-1 acts like a weak version of insulin), and severe low blood sugar has caused hospitalizations and deaths in enhancement use. For most people interested in recovery, GH-axis peptides get you to the same IGF-1 benefit with substantially less risk. Net: the biology is relevant; the direct injection route is not the right tool for most recovery goals.</p>
      </div>

      <div className="reta-overview__profile">
        <div className="reta-overview__profile-label">Profile 2</div>
        <h3 className="reta-overview__profile-heading">The Athlete &mdash; understanding GH effects, performance edge</h3>
        <blockquote className="reta-overview__profile-think">&ldquo;My coach mentioned that GH works mostly through IGF-1. Does injecting IGF-1 directly just skip the middleman and work better, or is there a reason everyone uses GH compounds instead?&rdquo;</blockquote>
        <p className="reta-overview__profile-why-heading">Why they&rsquo;re excited</p>
        <ol className="reta-overview__profile-why">
          <li><strong>Directly targeting the active growth signal sounds more efficient</strong><br />If GH&rsquo;s anabolic effects mostly come from the IGF-1 it triggers the liver to produce, injecting IGF-1 directly seems like it cuts out a step. The logic is understandable even if the conclusion is wrong.</li>
          <li><strong>Community history suggests real performance and composition effects</strong><br />IGF-1 has been used in competitive bodybuilding for decades, and user reports of significant muscle gains and accelerated recovery are consistent enough to reflect real pharmacological effects rather than placebo.</li>
        </ol>
        <p className="reta-overview__profile-check-heading">Reality check</p>
        <p className="reta-overview__profile-check">The &ldquo;skip the middleman&rdquo; logic breaks down because the middleman isn&rsquo;t just an inconvenient extra step &mdash; it&rsquo;s the feedback regulation that keeps IGF-1 at safe levels. GH-axis peptides work within that regulation. Direct IGF-1 injection doesn&rsquo;t. The practical consequence is a blood sugar drop risk that is immediate and serious &mdash; not a manageable side effect but a documented emergency risk that has sent people to hospitals. Beyond hypoglycemia, IGF-1 signals growth in every tissue including cancer cells. For an athlete without cancer it&rsquo;s a risk you can&rsquo;t see; for someone with an undetected tumor it can be accelerating. Net: GH-axis peptides achieve the IGF-1 benefit without bypassing the regulatory system; that&rsquo;s not a safety-first excuse but a genuine mechanistic reason to prefer them.</p>
      </div>

      <div className="reta-overview__profile">
        <div className="reta-overview__profile-label">Profile 3</div>
        <h3 className="reta-overview__profile-heading">The Biohacker &mdash; IGF-1 axis, aging paradox, cancer risk quantification</h3>
        <blockquote className="reta-overview__profile-think">&ldquo;High IGF-1 correlates with cancer risk in epidemiology but also correlates with muscle mass and possibly longevity. How do you think about the IGF-1 axis from a longevity optimization perspective?&rdquo;</blockquote>
        <p className="reta-overview__profile-why-heading">Why they&rsquo;re excited</p>
        <ol className="reta-overview__profile-why">
          <li><strong>The IGF-1 aging paradox is a real and interesting systems-level question</strong><br />Chronically elevated IGF-1 correlates with cancer risk. But low IGF-1 correlates with muscle loss, cognitive decline, and frailty. The sweet spot &mdash; keeping IGF-1 in a physiologically optimal range that preserves muscle and metabolism without excessive cancer-promoting activity &mdash; is a genuine axis of aging biology optimization. Understanding IGF-1 is prerequisite to understanding that optimization question.</li>
          <li><strong>The GH/IGF-1 axis is one of the better-mapped aging-relevant systems in biology</strong><br />The growth hormone axis has been studied extensively in the context of aging, and the literature is richer than for most other systems targeted in longevity protocols. The signal transduction pathways downstream of IGF-1R (mTOR, FOXO, Akt) are among the most studied in aging biology.</li>
        </ol>
        <p className="reta-overview__profile-check-heading">Reality check</p>
        <p className="reta-overview__profile-check">The longevity paradox of IGF-1 is real, and the resolution most longevity researchers favor is &ldquo;maintain adequate IGF-1 for tissue health but avoid supraphysiological levels.&rdquo; Direct IGF-1 injection &mdash; especially at doses that produce bodybuilding results &mdash; is supraphysiological signaling without the binding protein regulation that normally caps free IGF-1 exposure. The mitogenic cancer risk is not theoretical: the IGF-1 receptor is overexpressed in breast, prostate, colorectal, and lung cancers, and IGF-1R signaling is an active oncological drug target. GH-axis peptides that produce IGF-1 within the physiological range through natural liver production have a substantially different risk profile for the longevity-oriented user. Net: understanding IGF-1 is essential; using exogenous IGF-1 injection for longevity optimization is hard to square with the cancer risk evidence.</p>
      </div>

      <div className="reta-overview__bottom">
        <p className="reta-overview__bottom-heading">The honest bottom line</p>
        <div className="reta-overview__bottom-cols">
          <div className="reta-overview__bottom-col">
            <p className="reta-overview__bottom-col-heading">What IGF-1 is NOT</p>
            <ul className="reta-overview__bottom-list">
              <li>Not a wellness or optimization compound &mdash; this is a powerful growth factor with serious risks</li>
              <li>Not appropriate for anyone with cancer history &mdash; the mitogenic signal is direct and real</li>
              <li>Not a safer version of GH-axis peptides &mdash; it bypasses the regulatory feedback they work within</li>
              <li>Not suitable for gray-market sourcing where purity and concentration cannot be verified</li>
              <li>Not a replacement for physician oversight &mdash; baseline glucose, cancer screening, and IGF-1 levels are required minimum before use</li>
              <li>Not appropriate during pregnancy, breastfeeding, or adolescence</li>
            </ul>
          </div>
          <div className="reta-overview__bottom-col">
            <p className="reta-overview__bottom-col-heading">What makes it interesting</p>
            <ul className="reta-overview__bottom-list">
              <li>The primary mediator of growth hormone&rsquo;s anabolic effects &mdash; understanding it explains how the entire GH axis works</li>
              <li>FDA-approved pharmaceutical form (Increlex) exists for genuine pediatric deficiency, confirming the mechanism is real</li>
              <li>The IGF-1 aging paradox &mdash; simultaneously linked to cancer risk and muscle preservation &mdash; is one of the most interesting systems questions in longevity biology</li>
              <li>The downstream signaling pathways (mTOR, FOXO, Akt) are among the best-mapped in aging science</li>
            </ul>
          </div>
        </div>
      </div>

    </div>
  );
}
